Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

IMDX stock hub

Insight Molecular Diagnostics Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IMDXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

161.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IMDX

In the news

Latest news · IMDX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IMDX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001642380
Company name	Insight Molecular Diagnostics Inc.
Country	United States
Country code	US
Cusip	68235C206
Employees	58
Employees Change	9%
Employees Change Percent	18.37
Enterprise value	$153.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
Isin	US68235C2061
Last refreshed	2026-05-10
Market cap	$161.2M
Market cap category	Micro-Cap
Price	$5.01
Price currency	USD
Rev Per Employee	69,913.79x
Sector	Healthcare
Sic	2835
Symbol	IMDX
Website	https://www.imdxinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-31.16%
EV Sales Forward	45.94x
EV/Sales	37.75x
FCF yield	-15.74%
P/S ratio	39.74x
PS Forward	48.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	56.84%
Gross Profit	$2.3M
Gross Profit Growth	178.38%
Gross Profit Growth Q	-19.61%
Gross Profit Growth3 Y	209.17%
Net Income	$-50.2M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-1,238.52%
Profit Per Employee	$-865,897
ROA	-62.66
Roa5y	-26.54
ROCE	-222.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-25.87%
Cagr1y	77.1%
Cagr3y	-1.38%
Cagr5y	-43.32%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth	115.58x
Revenue Growth Q	-23.35x
Revenue Growth Years	3x
Revenue Growth3 Y	61.76x
Revenue Growth5 Y	27.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.13
Assets	$25.8M
Cash	$11.6M
Current Assets	$15.3M
Current Liabilities	$12.1M
Debt	$3.5M
Debt EBITDA	$0.01
Equity	$-31.5M
Interest Coverage	-279.8
Liabilities	$57.2M
Long Term Assets	$10.5M
Long Term Liabilities	$45.1M
Net Cash	$8.1M
Net Cash By Market Cap	$5.02
Net Cash Growth	62.63%
Tangible Book Value	$-31.5M
Tangible Book Value Per Share	$-1.1
WACC	12.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.27
Inventory Turnover	4.09
Net Working Capital	$-6.5M
Quick ratio	1.05
Working Capital	$3.2M
Working Capital Turnover	$1.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-133.16%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-94.99%
1Y total return	77.03%
200-day SMA	4.77
3Y total return	-4.1%
50-day SMA	4.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.15%
All Time High	204.8
All Time High Change	-97.55%
All Time High Date	2016-01-05
All Time Low	1.92
All Time Low Change	160.67%
All Time Low Date	2025-01-22
ATR	0.61
Beta	1.63
Beta1y	0.9
Beta2y	0.63
Ch YTD	-33.2
High	5.1
High52	8.51
High52 Date	2025-11-12
High52ch	-41.13%
Low	4.55
Low52	2.33
Low52 Date	2025-08-29
Low52ch	115.02%
Ma50ch	19.37%
Premarket Change Percent	-2.12
Premarket Price	$4.86
Premarket Volume	312
Price vs 200-day SMA	5.12%
RSI	60.11
RSI Monthly	47.26
RSI Weekly	50.92
Sharpe ratio	1.02x
Sortino ratio	1.72
Total Return	-133.16%
Tr YTD	-33.2
Tr1m	56.08%
Tr1w	19.86%
Tr3m	-31.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.26
Earnings Revenue Estimate	227,500x
Earnings Revenue Estimate Growth	-90.19x
Operating Income	$-30.5M
Operating margin	-752
Price target	$10.5
Price Target Change	$110

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,963,854%
Float Percent	30.97%
Net Borrowing	-510,000
Shares Insiders	12.25%
Shares Institutions	8.28%
Shares Out	32,167,978
Shares Qo Q	0.1%
Shares Yo Y	133.16%
Short Float	4.58%
Short Ratio	1.34
Short Shares	1.42

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-27.8M
Average Volume	490,289.3x
Bv Per Share	-1.1
CAPEX	$-3.2M
Ch10y	-94.99
Ch1m	56.08
Ch1w	19.86
Ch1y	77.03
Ch3m	-31.56
Ch3y	-4.1
Ch5y	-94.15
Ch6m	-19.71
Change	1.01%
Change From Open	2.87
Close	4.96
Days Gap	-1.81
Depreciation Amortization	2,197,000
Dollar Volume	2,115,141.8
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-30.5M
EBITDA	$-28.3M
EPS	$-1.65
F Score	3
FCF	$-25.4M
FCF EV Yield	-16.57x
FCF Per Share	$-0.79
Financing CF	28,072,000
Fiscal Year End	December
Founded	2,009
Investing CF	-3,185,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Last Split Date	2023-07-25
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	5.42
Ma150ch	-7.53%
Ma20	4.04
Ma20ch	23.92%
Net CF	2,583,000
Next Earnings Date	2026-05-13
Open	4.87
Optionable	Yes
Position In Range	83.64
Post Close	5.01
Postmarket Change Percent	-2
Postmarket Price	$4.91
Ppne	9,250,000
Pre Close	4.96
Price Date	2026-05-08
Relative Volume	0.86x
Revenue	4,055,000x
SBC By Revenue	58.77x
Share Based Comp	2,383,000
Tr6m	-19.71%
Us State	Tennessee
Volume	422,184
Z Score	-24.34

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IMDX pay a dividend?

Capital-return profile for this ticker.

Performance

IMDX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IMDX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.3%

Float: +31.0% of shares outstanding

Insider ownership

+12.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IMDX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.1

Neutral momentum band

Price vs 200-day MA

+5.1%

50/200-day relationship not available

Beta (5Y)

1.63

More volatile than the market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IMDX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IMDX stock rating?

Insight Molecular Diagnostics Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IMDX analysis?

The full report lives at /stocks/IMDX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IMDX?

The latest report frames IMDX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IMDX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.